Skip to content
The Nexus
DossierENTITY

Imperagen

Coverage of Imperagen in the Nexus archive.

Earliest in view: May 21 · 04:00 UTCMost recent: May 21 · 04:00 UTC
Co-mentioned in this coverage
PXN Venturesorganization1IQ Capitalorganization1Northern Gritstoneorganization1enzyme engineeringtopic1quantum physicstopic1artificial intelligencetopic1
Recent coverage
  • BUSINESSMay 21 · 04:00 UTCTECHCRUNCH
    Imperagen raises £5 million to use quantum physics, AI on enzyme engineering

    Biotech company Imperagen has secured £5 million ($6.7 million) in seed funding led by PXN Ventures to advance enzyme engineering using quantum physics and artificial intelligence. The round also includes participation from investors IQ Capital and Northern Gritstone.

Imperagen · Dossier · The Nexus